Recombinant FTL antibody (AA 38-165)
Quick Overview for Recombinant FTL antibody (AA 38-165) (ABIN7874492)
Target
See all FTL AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- AA 38-165
-
Purpose
- Recombinant FTL Antibody / Ferritin light chain (azide and preservative free)
-
Purification
- Protein G affinity chromatography
-
Immunogen
- A human recombinant partial protein (amino acids 38-165) was used as the immunogen for the recombinant FTL antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal dilution of the recombinant FTL antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the recombinant FTL antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- FTL (Ferritin, Light Polypeptide (FTL))
-
Alternative Name
- FTL
-
Background
- Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
-
UniProt
- P02792
-
Pathways
- Transition Metal Ion Homeostasis
Target
-